Analysis of Parental Support in Families Using the LENA After Early Cochlear Implantation

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age11-21
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

The language environment that influences the child's language development has been studied using different subjective tools, mainly audio and/or video recording and manual transcriptions. The linguistic results of the implanted deaf child are dependent on the age at the implant, but also on the auditory and linguistic stimulation in the first months following the placement of the implant. Parents are the main actors in the child's language development. Professionals can rely on the LENA tool: Language ENvironment Analysis, which objectifies the language environment of the child at home in his daily environment. It is possible to obtain statistics on the number of adult words received by the child, the number of words produced by the child as well as the exposure to media and noise. On the basis of this quantitative data, the family can be supported in an attempt to optimize the conditions for receiving their child's speech.

The purpose of this study is to analyze the effect of speech therapy parental support using the data provided by the Language ENvironment Analysis (LENA) tool, in a pediatric population implanted early, i.e. before the age of 18 months and aged under 24 months inclusive at the start of their participation in the study.

Eligibility criteria

Qualifiers

Have profound congenital deafness

Have been implanted between 8 months and 18 months

Have had a unilateral or bilateral cochlear implant for 3 months

Be between 11 months and 21 months old on the day of inclusion

Disqualifiers

Syndromic deafness or auditory nerve aplasia

Micro-cochlea or partial insertion of the electrode bundle

CHARGE syndrome (acronym for Coloboma, Heart defect, Atresia choanae, Retarded growth and development, Genital hypoplasia, Ear anomalies/deafness or in French coloboma, cardiac malformation, choanal atresia, growth retardation and/or mental retardation, genital hypoplasia, ear abnormalities/deafness)

Deafness with significant central involvement (cytomegalovirus, meningitis)

Trial design

Treatments tested in this trial

  • LENA tool: Language ENvironment Analysis
  • Return of the analysis of the data of LENA

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators

Assistance Publique - Hôpitaux de Paris

Lead sponsor

URC-CIC Paris Descartes Necker Cochin

Collaborator